Endothelium-dependent relaxation and angiotensin II sensitivity in experimental preeclampsia

PLoS One. 2013 Nov 6;8(11):e79884. doi: 10.1371/journal.pone.0079884. eCollection 2013.

Abstract

Objective: We investigated endothelial dysfunction and the role of angiotensin (Ang)-II type I (AT1-R) and type II (AT2-R) receptor in the changes in the Ang-II sensitivity in experimental preeclampsia in the rat.

Methods: Aortic rings were isolated from low dose lipopolysaccharide (LPS) infused pregnant rats (experimental preeclampsia; n=9), saline-infused pregnant rats (n=8), and saline (n=8) and LPS (n=8) infused non-pregnant rats. Endothelium-dependent acetylcholine-mediated relaxation was studied in phenylephrine-preconstricted aortic rings in the presence of vehicle, N(G)-nitro-L-arginine methyl ester and/or indomethacin. To evaluate the role for AT1-R and AT2-R in Ang-II sensitivity, full concentration response curves were obtained for Ang-II in the presence of losartan or PD123319. mRNA expression of the AT1-R and AT2-R, eNOS and iNOS, COX1 and COX2 in aorta were evaluated using real-time RT-PCR.

Results: The role of vasodilator prostaglandins in the aorta was increased and the role of endothelium-derived hyperpolarizing factor and response of the AT1-R and AT2-R to Ang-II was decreased in pregnant saline infused rats as compared with non-pregnant rats. These changes were not observed during preeclampsia.

Conclusion: Pregnancy induced adaptations in endothelial function, which were not observed in the rat model for preeclampsia. This role of lack of pregnancy induced endothelial adaptation in the pathophysiology of experimental preeclampsia needs further investigation.

MeSH terms

  • Angiotensin II / metabolism*
  • Angiotensin II Type 1 Receptor Blockers / pharmacology
  • Animals
  • Aorta / drug effects
  • Aorta / metabolism
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 2 / genetics
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Female
  • Imidazoles / pharmacology
  • Lipopolysaccharides / pharmacology
  • Losartan / pharmacology
  • Nitric Oxide Synthase Type II / genetics
  • Pre-Eclampsia / metabolism*
  • Pregnancy
  • Prostaglandins / metabolism
  • Pyridines / pharmacology
  • Rats
  • Receptor, Angiotensin, Type 1 / genetics
  • Receptor, Angiotensin, Type 1 / metabolism
  • Receptor, Angiotensin, Type 2 / genetics
  • Receptor, Angiotensin, Type 2 / metabolism
  • Vasodilator Agents / pharmacology

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Imidazoles
  • Lipopolysaccharides
  • Prostaglandins
  • Pyridines
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Vasodilator Agents
  • Angiotensin II
  • PD 123319
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Losartan

Grants and funding

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding was received for this study.